Onconetix, Inc. (ONCO) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Onconetix, Inc. on January 24, 2025, regarding an event dated January 23, 2025. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Cincinnati, Ohio. Its common stock trades on The Nasdaq Capital Market under the symbol "ONCO".
Key Financial Metrics
This filing is a notice of a listing deficiency and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The material change reported is the receipt of a notice from The Nasdaq Stock Market LLC indicating non-compliance with the minimum bid price requirement for continued listing.
- Deficiency: The Company's common stock closing bid price remained below $1.00 per share for the period from November 25, 2024, to January 10, 2025.
- Current Status: The notice has no immediate effect on the listing status; the stock remains fully effective on The Nasdaq Capital Market.
Outlook, Risks, and Contingencies
The Company has been granted an initial compliance period of 180 calendar days, ending July 22, 2025, to regain compliance.
- Compliance Path: To resolve the matter, the closing bid price must close at or above $1.00 per share for a minimum of 10 consecutive business days before July 22, 2025.
- Extension Possibility: If compliance is not met by the initial deadline, Nasdaq may grant a second 180-day period, provided the Company meets other listing standards (e.g., market value of publicly-held shares) and notifies Nasdaq of its intent to cure.
- Risk of Delisting: If the Company fails to regain compliance within the allotted periods, Nasdaq will provide notice of delisting. The Company would then be entitled to appeal to a Nasdaq hearings panel.
- Uncertainty: There is no assurance that the Company will regain compliance or maintain other listing requirements.
Key Facts for Investor Verification
- Verify the current closing bid price of ONCO stock to assess proximity to the $1.00 threshold.
- Monitor the stock price for 10 consecutive trading days above $1.00 to confirm potential resolution of the deficiency.
- Review future filings to determine if the Company intends to seek a second 180-day compliance period if the initial deadline is missed.
- Check for any announcements regarding a reverse stock split or other corporate actions intended to increase the share price.